Pharmabiz5h
Tiziana Life Sciences gets US FDA permission to enroll additional patients in intranasal foralumab multiple sclerosis expanded access programme
Tiziana Life Sciences gets US FDA permission to enroll additional patients in intranasal foralumab multiple sclerosis expanded access programme: New York Thursday, April 25, 2024, ...
Pharmabiz7h
Wincal Biopharm to present preclinical data from its Ocular Penetration Carrier Platform at ARVO 2024 annual meet from May 5 to 9, 2024
Wincal Biopharm to present preclinical data from its Ocular Penetration Carrier Platform at ARVO 2024 annual meet from May 5 to 9, 2024: South San Francisco Thursday, April 25, 20 ...
Pharmabiz6h
ImmunityBio gets US FDA nod for its Anktiva to treat patient with BCG-unresponsive non-muscle invasive bladder cancer
ImmunityBio gets US FDA nod for its Anktiva to treat patient with BCG-unresponsive non-muscle invasive bladder cancer: Culver City, California Thursday, April 25, 2024, 17:00 Hrs ...
Pharmabiz7h
Lupin receives US FDA approval for loteprednol etabonate ophthalmic suspension, 0.5%
Lupin receives US FDA approval for loteprednol etabonate ophthalmic suspension, 0.5%: Our Bureau, Mumbai Thursday, April 25, 2024, 16:15 Hrs [IST] Global pharma major Lupin Limite ...
Pharmabiz6h
Apollo Greams Road receives JCI accreditations
Apollo Hospitals Group announced its seventh consecutive accreditation by the Joint Commission International (JCI) for its flagship hospital, Apollo Greams Road. This prestigious recognition reaffirms ...
Pharmabiz7h
Promising patient-friendly oral drug against visceral leishmaniasis enters phase II clinical trial in Ethiopia
Promising patient-friendly oral drug against visceral leishmaniasis enters phase II clinical trial in Ethiopia: Geneva Thursday, April 25, 2024, 16:00 Hrs [IST] An innovative, saf ...
Pharmabiz9h
Regeneration Biomedical doses first patient in phase I trial of stem cell therapy to deliver directly to brain of Alzheimer’s disease patients
Newport Beach, California Thursday, April 25, 2024, 14:00 Hrs [IST] ...
Pharmabiz11h
Novartis, MMV announce positive data from phase II/III CALINA study of Coartem to treat babies 5 kg with malaria
Novartis, MMV announce positive data from phase II/III CALINA study of Coartem to treat babies 5 kg with malaria: Basel Thursday, April 25, 2024, 12:00 Hrs [IST] Novartis and Medi ...
Pharmabiz11h
King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, Hinduja Hospital & Hinduja Foundation establish health partners academy
King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, Hinduja Hospital & Hinduja Foundation establish health partners academy: Our Bureau, Mumbai Thursday, April ...
Pharmabiz10h
US FDA grants accelerated approval to Day One Biopharma’s tovorafenib to treat relapsed or refractory BRAF-altered paediatric low-grade glioma
US FDA grants accelerated approval to Day One Biopharma’s tovorafenib to treat relapsed or refractory BRAF-altered paediatric low-grade glioma: Brisbane, California Thursday, Ap ...
Pharmabiz12h
EC grants label extension approval for Astellas’ Xtandi for use in additional recurrent early prostate cancer treatment setting
EC grants label extension approval for Astellas’ Xtandi for use in additional recurrent early prostate cancer treatment setting: Tokyo Thursday, April 25, 2024, 11:00 Hrs [IST] ...
Pharmabiz10h
SMBXL hosts India’s largest online B2B and B2C Hospital and Medical Supplies Expo
SMBXL hosts India’s largest online B2B and B2C Hospital and Medical Supplies Expo: Our Bureau, Mumbai Thursday, April 25, 2024, 13:30 Hrs [IST] SMBXL, a leading technology compa ...